Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term pharmacokinetics and pharmacodynamics of Landiolol vs Esmolol in healthy volunteers
2010-023311-34Phase 2Completed
- Sponsor
- AOP Health
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of landiolol in sinus tachycardia (ST) (2 arms), sponsored by AOP Health. Primary endpoint: Short-term pharmacokinetics of Landiolol vs Esmolol. Started Dec 2010; status: completed.
02
Drugs
landiolol
03
Conditions
sinus tachycardia (ST)
Beyond the preview
Go deeper on 2010-023311-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023311-34.